News und Analysen
PerkinElmer to Present at Stifel Virtual Healthcare Conference
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Stifel Virtual Healthcare Conference on Tuesday
Bristol Myers Squibb and MyoKardia Announce Expiration of HSR Act Waiting Period
Bristol Myers Squibb (NYSE: BMY) and MyoKardia, Inc. (Nasdaq: MYOK) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act
Waters Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact RADIAN ASAP System
Waters Corporation (NYSE:WAT) today introduced the new RADIAN™ ASAP™ System, a novel direct mass detector engineered for non-mass spectrometry (MS) experts to conduct fast and accurate analyses of
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn
Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the “FTC”) accepted a proposed consent order, which concludes the FTC’s review of the
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2020.
Third quarter 2020 results reflect strong sequential growth:
-
Revenue of $794
PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization for Sample Pooling
PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow sample pooling with PerkinElmer® New Coronavirus
Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting
Agilent Technologies Inc. (NYSE: A) will release fourth-quarter fiscal year 2020 financial results after the stock market closes on Monday, Nov. 23. The company will host a live webcast of its
PerkinElmer Announces Financial Results for the Third Quarter of 2020
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended October 4, 2020.
The Company reported
Southwestern Health Resources and Humana Announce Value-Based Agreement in North Texas
Southwestern Health Resources (SWHR) – the clinically integrated network for University of Texas Southwestern Medical Center (UT Southwestern), Texas Health Resources, and more than 5,000
Agreement with UCHealth Expands Humana’s Medicare Advantage Provider Network in the Rocky Mountain Region
UCHealth and Humana Inc. (NYSE: HUM), a leading health and well-being company, have signed an in-network agreement for UCHealth University of Colorado Hospital on the Anschutz Medical Campus in
PFIZER REPORTS THIRD-QUARTER 2020 RESULTS
Pfizer Inc. (NYSE: PFE) reported financial results for third-quarter 2020 and updated and tightened certain components of Total Company(3) 2020 financial guidance, which continues to reflect actual
FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitis
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) accepted for filing and granted Priority Review designation to the company’s New Drug Application (NDA) for
PerkinElmer erhält CE-Kennzeichnung für auf Atemwegsinfektionen, einschließlich COVID-19, ausgerichtetes Multi-Analyt-Panel
PerkinElmer, Inc. (NYSE: PKI) meldete heute, dass sein PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel die Zulassung für die Vermarktung als In-vitro-Diagnostikum (IVD) in mehr als 30 Ländern im Sinne
PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19
PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic (IVD) device in more than 30
PerkinElmer Board Declares Quarterly Dividend
The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock October 22, 2020. This dividend is payable on February 12, 2021 to
Humana, Quantified Ventures, and Volunteers of America Partner to Establish First of Its Kind Health Outcomes Fund
Humana Inc. (NYSE: HUM) today re-confirms its commitment to provide innovative models of care for families through a catalytic investment of $5 million in an outcomes-based fund, supported by
University Medical Center and Humana Sign Agreement, Expanding Humana’s Medicare Advantage Provider Network in New Orleans
University Medical Center New Orleans, a part of LCMC Health, and Humana Inc. (NYSE: HUM), a leading health and well-being company, have signed an in-network agreement, expanding access to care for
Humana Joins Forces with DAV (Disabled American Veterans)
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, has entered into an agreement with DAV (Disabled American Veterans), an organization whose mission is
Data From Pfizer’s Adult and Pediatric Clinical Trial Programs for 20-Valent Pneumococcal Conjugate Vaccine Presented at IDWeek 2020
Pfizer Inc. (NYSE:PFE) today announced the full analysis from one of its Phase 3 studies (NCT03760146), which evaluated the safety and immunogenicity of its 20-valent pneumococcal conjugate vaccine
Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020
Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260, and 1290 Infinity II LC product families have received the My Green Lab accountability, consistency, and transparency
Agilent Vaya Raman Raw Material ID Verification System Receives 2020 R&D 100 Award
Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Vaya Raman raw material identity verification system has received a 2020 R&D 100 Award in the Analytical/Test category. The
Humana Announces Major Tennessee Expansion, Will Sell Medicare Advantage Plans in 31 More Counties
As part of Humana Inc.’s (NYSE: HUM) major Tennessee expansion in 2021, the leading health and well-being company announced today it is introducing a new Medicare Advantage Health Maintenance
Waters ACQUITY PREMIER Columns Set a New Standard of Performance for Chromatographic Analyses
Waters Corporation (NYSE:WAT) today introduced ACQUITY™ PREMIER Columns, a new family of premium sub-2-micron columns featuring MaxPeak™ High Performance Surface (HPS) technology. The columns are
Agilent Early Career Professor Award Presented to Carl DeSelm
Agilent Technologies Inc. (NYSE: A) today announced that Carl DeSelm, M.D., Ph.D., has received the 2020 Agilent Early Career Professor Award. Dr. DeSelm is an assistant professor of Radiation
Humana Welcomes Additional Retail Pharmacies to Preferred Medicare Part D Network
Humana Inc. (NYSE: HUM), a leading health and well-being company, has announced that Kroger Health and its family of pharmacies, Costco, Publix and HEB have joined its preferred stand-alone